Related Experiment Video
Updated: Jun 8, 2025
07:56
Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
10.5K
Approach to neonatal thrombocytopenia.
Megan Dunlop1, Nick Fordham2, Timothy Watts1
1Neonatal Intensive Care Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Archives of Disease in Childhood. Education and Practice Edition
|November 1, 2024
Summary
Neonatal thrombocytopenia, a low platelet count in newborns, presents diagnostic challenges. Understanding its causes and progression is key to effective interpretation and management in the neonatal intensive care unit.
Area of Science:
- Neonatal Medicine
- Hematology
Background:
- Low platelet count (thrombocytopenia) is frequent in neonatal intensive care units.
- Neonatal thrombocytopenia has diverse etiologies, complicating assessment and treatment.
Purpose of the Study:
- To explore the various causes of neonatal thrombocytopenia.
- To guide the interpretation and management of thrombocytopenic neonates.
Main Methods:
- Review of existing literature on neonatal thrombocytopenia.
- Analysis of common and critical causes.
- Discussion of diagnostic approaches and treatment strategies.
Main Results:
- Identification of key etiological categories for neonatal thrombocytopenia.
- Outline of natural progression patterns for different causes.
- Framework for clinical interpretation and management decisions.
Conclusions:
- A systematic approach to understanding causes and progression aids in managing neonatal thrombocytopenia.
- Effective interpretation and management strategies are crucial for affected neonates.
Related Concept Videos
01:24Disorders of Hemostasis
716
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
716
01:22Formation of the Platelet Plug
4.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.6K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
624
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624
01:05Introduction to Hemostasis
5.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.9K